Analysis: #NASDAQ
Case 492 #Catalyst Pharmaceuticals Inc.
DISCLAIMER: The analysis is strictly for educational purposes and should not be construed as an invitation to trade.
#CPRX 1/5
Chart 1
Weekly Chart: Price is being held down by the #SMA 200 and is about to run into 2016 trendline #support at 2.74 with good buying interest at 2.38/19. Below the Mar. 2017 #pivot at 1.95 and farther down synthetic sloping at 1.50 with control at 1.47. To .....
CPRX 2/5
..... the upside, notable #resistance seen at the #Fib .50 at 4.13 (bottom of May-July range) then Sept. 2019 #trendline resistance at 4.44. Sales and profit taking has been consistent and constant into 5.06/19 and higher up the #confluence of .....
CPRX 3/5
..... synthetic #resistance and control at 5.90 colliding in Apr. 2021. A close/hold above targets the balance point at 7.26.
CPRX 4/5
Chart 2
Daily Chart: The SMA 200 is touching Fib. 50. Watch closely 2.75/57 to initiate the position.
The #Strategy is printed on the image.
5/5
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.